1. Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity Izzo, Nicholas J.; Xu, Jinbin; Zeng, Chenbo; Kirk, Molly J.; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Cruchaga, Carlos; Goate, Alison; Cahill, Michael A.; Arancio, Ottavio; Mach, Robert H.; Craven, Rolf; Head, Elizabeth; LeVine III, Harry; Spires-Jones, Tara L.; Catalano, Susan M. 2014 Articles OligomersTherapeuticsAlzheimer's diseaseNeurosciencesCytologyMedical sciences
2. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists Frank-Kamenetsky, Maria; Zhang, Xiaoyan; Bottega, Steve; Guicherit, Oivin; Wichterle, Hynek; Dudek, Henryk; Bumcrot, David; Wang, Frank; Jones, Simon; Shulok, Janine; Rubin, Lee; Porter, Jeffery 2002 Articles TherapeuticsCellular signal transductionCytologyMolecular biology